p63 immunohistochemistry in the distinction of adenoid cystic carcinoma from basaloid squamous cell carcinoma

Modern Pathology

Volumn 18, Issue 5, 2005, Pages 645-650

  Emanuel, Patrick ^a   Wang, Beverly ^a   Wu, Maoxin ^a   Burstein, David E ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Adenoid cystic carcinoma; Basaloid squamous cell carcinoma; Immunohistochemistry; p63; Salivary gland; Tumor markers

Indexed keywords

BIOTIN; DIAMINOBENZIDINE; MONOCLONAL ANTIBODY; PROTEIN P63; REGULATOR PROTEIN; STREPTAVIDIN;

ACCURACY; ADENOID CYSTIC CARCINOMA; ARTICLE; CANCER DIAGNOSIS; CELL COMPARTMENTALIZATION; CELLULAR DISTRIBUTION; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA;

CARCINOMA, ADENOID CYSTIC; CARCINOMA, BASOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; DIAGNOSIS, DIFFERENTIAL; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; PHOSPHOPROTEINS; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEINS;

EID: 18744399314     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800329     Document Type: Article

References (25)

1. Rosai J. Surgical Pathology, 9th edn. Mosby: New York, 2004, pp 258-259, 631.
2. Armstrong JG, Harrison LB, Spiro RH, et al. Malignant tumors of major salivary gland origin. Arch Otolaryngol Head Neck Surg 1990;116:290-293.
3. Sadeghi A, Tran LM, Mark R, et al. Minor salivary tumors of the head and neck: treatment strategies and prognosis. Am J Clin Oncol 1993;16:3-8.
4. Koide N, Kishimoto K, Nakamura T, et al. Basaloid-squamous carcinoma of the esophagus treated by preoperative chemotherapy: report of two cases. Surg Today 2003;33:444-447.
5. Yang A, Kaghad M, Caput D, et al. On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet 2002;18:90-95.
6. King KE, Ponnamperuma RM, Yamashita T, et al. DeltaNp63alpha functions as both a positive and a negative transcriptional regulator and blocks in vitro differentiation of murine keratinocytes. Oncogene 2003;22:3635-3644.
7. Yang A, Schweitzer R, Sun D, et al. P63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999;398:714-718.
8. Mills AA, Zheng B, Wang XJ, et al. P63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999;398:708-713.
9. Di Como CJ, Urist MJ, Babayan I, et al. P63 expression profiles in human normal and tumor tissues. Clin Cancer Res 2002;8:494-501.
10. Signoretti S, Waltregny D, Dilks J, et al. P63 is a prostate basal cell marker and is required for prostate development. Am J Surg Pathol 2000;157:1769-1775.
11. Barbareschi M, Pecciarini L, Cangi MG, et al. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol 2001;25:1054-1060.
12. Wang BY, Gil J, Burstein DE, et al. p63 in pulmonary epithelium, pulmonary squamous neoplasms and other pulmonary tumors. Hum Pathol 2002;33:921-926.
13. Nylander K, Coates PJ, Hall PA. Characterization of the expression pattern of p63 alpha and delta Np63alpha in benign and malignant oral epithelial lesions. Int J Cancer 2000;87:368-372.
14. Quade BJ, Yang A, Wang Y, et al. Expression of the p53 homologue p63 in early cervical neoplasia. Gynecol Oncol 2001;80:24-29.
15. Wang TY, Chen BF, Yang YC, et al. Histologic and immunophenotypic classification of cervical carcinomas by expression of the p53 homologue p63: a study of 250 cases. Hum Pathol 2001;32:479-486.
16. Glickman JN, Yang A, Shahsafaei A, et al. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders. Hum Pathol 2001;32:1157-1165.
17. Park BJ, Lee SJ, Kim JI, et al. Frequent alteration of p63 expression in human primary bladder carcinomas. Cancer Res 2000;60:3370-3374.
18. O'Connell JT, Mutter GL, Cviko A, et al. Identification of a basal/reserve cell immunophenotype in benign and neoplastic endometrium: a study with the p53 homologue p63. Gynecol Oncol 2001;80:30-36.
19. Unger P, Ewart M, Wang BY, et al. Expression of p63 in papillary thyroid carcinoma and in Hashimoto's thyroiditis: a pathobiologic link? Hum Pathol 2003;34:764-769.
20. Chilosi M, Zamo A, Brighenti A, et al. Constitutive expression of DeltaN-p63alpha isoform in human thymus and thymic epithelial tumours. Virchows Arch 2003;443:175-183.
21. Weber A, Langhanki L, Schutz A, et al. Expression profiles of p53, p63, and p73 in benign salivary gland tumors. Virchows Arch 2002;441:428-436.
22. Bilal H, Handra-Luca A, Bertrand JC, et al. P63 is expressed in basal and myoepithelial cells of human normal and tumor salivary gland tissues. J Histochem Cytochem 2003;51:133-139.
23. Black CC, Unger PD, Burstein DE, et al. Expression of p63 protein in subtypes of transitional cell and renal cell carcinoma. Mod Pathol 2002;14:102A.
24. Stefanou D, Batistatou A, Nonni A, et al. P63 expression in benign and malignant breast lesions. Histol Histopathol 2004;19:465-471.
25. Shah RB, Zhou M, LeBlanc M, et al. Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer. Am J Surg Pathol 2002;26:1161-1168.